 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration |
| Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim |
|
J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online September 15, 2021 DOI: https://doi.org/10.3341/jkos.2021.62.9.1218 |
|
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration Journal of the Korean Ophthalmological Society. 2021;62(9):1218-1226  Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept BMC Ophthalmology. 2018;18(1): Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept Journal of the Korean Ophthalmological Society. 2022;63(6):526-534 Short-term Efficacy of Brolucizumab Injection for Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept Journal of Retina. 2021;6(2):145-149 Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration Clinical Ophthalmology. 2015;1315 Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration Clinical Ophthalmology. 2013;495 Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration Survey of Ophthalmology. 2018;63(5):638-645 Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye Clinical Ophthalmology. 2014;2129 Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis Clinical Ophthalmology. 2017;Volume 11:161-177 Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept Journal Français d'Ophtalmologie. 2017;40(10):832-838 |
